Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal)

Technology appraisal
Reference number: TA884
Published: 03 May 2023

History

Invitation to participate

Final scope (PDF 272 KB)

Published:

07 February 2022
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 208 KB)

Published:

07 February 2022
Equality impact assessment (Scoping) (PDF 128 KB)

Published:

07 February 2022
Final stakeholder list (PDF 193 KB)

Published:

07 February 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 293 KB)

Published:

09 July 2021
Draft matrix post referral (PDF 191 KB)

Published:

09 July 2021